BioPharma Resources

Drugs by condition

Drugs approved for insomnia

Brand-name prescription drugs and biologics whose FDA label lists insomnia as an approved use. Matched on the label phrases: "insomnia".

Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

16

Still marketed, NDA or BLA

Drug classes

5

Novel drugs

10

New molecular entities and new biologics

In development

7

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for insomnia.

  • Zolpidem Tartrate (Zolpidem Tartrate) · Almatica May 9, 2023
  • Quviviq (Daridorexant Hydrochloride) · Idorsia NovelJan 7, 2022
  • Dayvigo (Lemborexant) · Eisai INC NovelDec 20, 2019
  • Mydayis (Amphetamine Aspartate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate) · Takeda Pharms USA Jun 20, 2017
  • Belsomra (Suvorexant) · Merck Sharp Dohme NovelAug 13, 2014

All approved drugs for insomnia, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 111 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Orexin Receptor Antagonist (3)

  • Quviviq Daridorexant Hydrochloride · Idorsia · 2022
  • Dayvigo Lemborexant · Eisai INC · 2019
  • Belsomra Suvorexant · Merck Sharp Dohme · 2014

Benzodiazepine (3)

  • Doral Quazepam · Galt Pharms · 1985
  • Halcion Triazolam · Pfizer · 1982
  • Restoril Temazepam · Specgx LLC · 1981

Melatonin Receptor Agonist (1)

  • Rozerem Ramelteon · Takeda Pharms USA · 2005

Monoamine Oxidase Inhibitor (1)

  • Marplan Isocarboxazid · Lifsa Drugs · 1959

Class not listed in FDA's data (8)

  • Lunesta Eszopiclone · Waylis Therap · 2004
  • Ambien Zolpidem Tartrate · Cosette · 1992
  • Zolpidem Tartrate Zolpidem Tartrate · Almatica · 2023
  • Mydayis Amphetamine Aspartate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate · Takeda Pharms USA · 2017
  • Silenor Doxepin Hydrochloride · Currax · 2010
  • Edluar Zolpidem Tartrate · Viatris · 2009
  • Venlafaxine Hydrochloride Venlafaxine Hydrochloride · Osmotica Pharm US · 2008
  • Ambien Cr Zolpidem Tartrate · Cosette · 2005

Drugs in development for insomnia

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • HS-10506Phase 32 trials

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Insomnia Disorder

  • YZJ-1139Phase 31 trial

    Shanghai Haiyan Pharmaceutical Technology Co., Ltd. · Insomnia Disorder

  • RE03Phase 21 trial

    Reconnect Labs · Posttraumatic Stress Disorder (PTSD), Sleep Disturbances and Insomnia

  • SOM001-APhase 21 trial

    Somnum Pharma Inc. · Chronic Insomnia

  • SOM001-BPhase 21 trial

    Somnum Pharma Inc. · Chronic Insomnia

  • SOM001-CPhase 21 trial

    Somnum Pharma Inc. · Chronic Insomnia

  • SOM001-DPhase 21 trial

    Somnum Pharma Inc. · Chronic Insomnia

More on insomnia: recruiting trials · published research

Related in psychiatry: Depression (major depressive disorder) · Schizophrenia · Bipolar disorder · ADHD · Anxiety disorders · Opioid use disorder · Alcohol dependence · Smoking cessation · PTSD · Postpartum depression

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.